ICD-10-CM Billable Code

H16.40

Unspecified corneal neovascularization

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified corneal neovascularization is a condition characterized by abnormal growth of blood vessels into the cornea, the clear front surface of the eye. Normally, the cornea lacks blood vessels to maintain clear vision. When new, fragile blood vessels form within the cornea, it can lead to visual disturbances and potential complications. This condition is classified under ICD-10 code H16.40 and is considered an ocular health concern that requires proper evaluation and management.

Causes & Symptoms

Clinical Causes: Chronic eye inflammation or ulcers Contact lens overuse or poor hygiene Corneal injury or trauma Previous eye surgeries, such as corneal transplants Oxygen deficiency in the eye tissues Certain systemic or ocular infections Ongoing hypoxia or ischemia of the corneal tissues

Key Symptoms: Redness or redness persistent in the affected eye Blurred or decreased vision Sensitivity to light (photophobia) Presence of visible blood vessels in the cornea Discomfort or a foreign body sensation Light-colored or grayish vessels seen on the corneal surface

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive eye examination by an ophthalmologist. The eye specialist will perform slit-lamp biomicroscopy to observe the corneal surface closely. Additional tests, such as fluorescein staining, may be used to assess corneal health. Imaging techniques like anterior segment Optical Coherence Tomography (OCT) can help evaluate the extent of neovascularization. A detailed patient history is crucial to identify potential causes and contributing factors.

Treatment Protocols: Management strategies for corneal neovascularization focus on controlling underlying causes and preventing progression. Approaches include: - **Medical Therapy:** Use of corticosteroids or anti-inflammatory medications to reduce inflammation, and anti-VEGF (vascular endothelial growth factor) agents to inhibit new blood vessel formation. - **Addressing Risk Factors:** Proper contact lens hygiene, managing infections promptly, and avoiding environmental factors that contribute to hypoxia. - **Laser Therapy:** Laser photocoagulation may be employed to destroy abnormal vessels. - **Surgical Intervention:** In severe or refractory cases, procedures such as corneal transplantation or vascular occlusion surgeries might be considered. Early detection and prompt management are vital to preserve vision and prevent further corneal damage.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H16.40 a billable ICD-10 code?
Yes, H16.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H16.40?
Clinical documentation must specify the nature of Unspecified corneal neovascularization and any associated comorbidities for accurate reporting.

Cite this Clinical Reference